2014
DOI: 10.5144/0256-4947.2014.270
|View full text |Cite
|
Sign up to set email alerts
|

Reply to RE: Steroid-resistant nephrotic syndrome: impact of genetic testing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 7 publications
1
1
0
Order By: Relevance
“…In other studies of New Zealand and Saudi Arabia showed that the mean age patients was 5.4 ± 3.9 and 4.3 ± 3.1 years, respectively. 9,10 The present study also showed that most of the childhood Nephrotic Syndrome was aged between 2 to 8 years (75.0%), whereas 9 (20.5%) patients were in the age group of above 8 years and only 2 (4.5%) patients were in the age group of below 2 years. In another Iranian study, 62.5% patients were in the range of 2-8 years.…”
Section: Discussionsupporting
confidence: 74%
“…In other studies of New Zealand and Saudi Arabia showed that the mean age patients was 5.4 ± 3.9 and 4.3 ± 3.1 years, respectively. 9,10 The present study also showed that most of the childhood Nephrotic Syndrome was aged between 2 to 8 years (75.0%), whereas 9 (20.5%) patients were in the age group of above 8 years and only 2 (4.5%) patients were in the age group of below 2 years. In another Iranian study, 62.5% patients were in the range of 2-8 years.…”
Section: Discussionsupporting
confidence: 74%
“…[8][9][10][11][12] Furthermore, reports indicated that the number of cases with SRNS is escalating which is likely attributed to the growing number of cases diagnosed with FSGS worldwide (including Iraq). [13][14][15][16] FSGS is the second leading cause of the end-stage renal disease (ESRD) and chronic renal failure in childhood. 17,18 https://he02.tci-thaijo.org/index.php/sirirajmedj/index Original Article SMJ Responsiveness to steroid therapy has been reported to provide a better prediction of prognosis as compared to a renal biopsy study.…”
Section: Introductionmentioning
confidence: 99%